- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Lupin Limited — Updates, 24-02-2026: Press Release
24-02-2026 | 07:13 pm
24-02-2026 | 07:13 pm
Lupin secured U.S. FDA approval and launched Brivaracetam Oral Solution for partial-onset seizures. The reference drug had estimated annual U.S. sales of $13.5 Cr, enhancing Lupin's position in a key therapeutic area.
No comments yet. Be the first to comment!